Robert D. Legare
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Breast Cancer Treatment Studies 10
- Oncology 17
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 7
- Co-authors
- Don S. DizonTina RizackAshley StuckeyC.O. GranaiJorge J. CastilloAnthony MegaRochelle StrengerWilliam M. Sikov
- Journals
- Journal of Clinical Oncology (7 papers)Gynecologic Oncology (5 papers)Obstetrics and Gynecology Clinics of North America (2 papers)American Journal of Hematology (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesSwitzerlandIsrael
In The Last Decade
Robert D. Legare
33 papers receiving 800 citations
Peers
Comparison fields: 5 of 77
- Oncology 449
- Cancer Research 230
- Reproductive Medicine 90
- Genetics 233
- Hematology 75
Countries citing papers authored by Robert D. Legare
This map shows the geographic impact of Robert D. Legare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Legare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Legare more than expected).
Fields of papers citing papers by Robert D. Legare
This network shows the impact of papers produced by Robert D. Legare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Legare. The network helps show where Robert D. Legare may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert D. Legare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 2 | |
| 3 | 2019 | 9 | |
| 4 | 2015 | 87 | |
| 5 | 2015 | 92 | |
| 6 | 2012 | 8 | |
| 7 | 2011 | 0 | |
| 8 | 2010 | 2 | |
| 9 | 2009 | 30 | |
| 10 | 2009 | 85 | |
| 11 | 2009 | 62 | |
| 12 | 2008 | 10 | |
| 13 | 2006 | 56 | |
| 14 | 2005 | 36 | |
| 15 | 2005 | 9 | |
| 16 | 2002 | 7 | |
| 17 | 2002 | 19 | |
| 18 | 1998 | 34 | |
| 19 | 1997 | 15 | |
| 20 | 1995 | 12 |
About Robert D. Legare
Robert D. Legare is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Hematology and Genetics, having authored 35 papers that have together received 822 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (10 papers), BRCA gene mutations in cancer (9 papers), HER2/EGFR in Cancer Research (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Advanced Breast Cancer Therapies (4 papers), Acute Myeloid Leukemia Research (4 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Oncology (449 citations), Cancer Research (230 citations), Reproductive Medicine (90 citations), Genetics (233 citations) and Hematology (75 citations). Robert D. Legare has collaborated with scholars based in United States, Switzerland and Israel. Frequent co-authors include Don S. Dizon, Tina Rizack, Ashley Stuckey, C.O. Granai, Jorge J. Castillo, Anthony Mega, Rochelle Strenger, William M. Sikov, Mary Anne Fenton and Vrishali Lopes. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Obstetrics and Gynecology Clinics of North America, American Journal of Hematology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.